Hemocromatosis

A double-blind, placebo-controlled study of the Andrographis paniculata combination product Kan Jang in 185 adults with acute URTIs including sinusitis found treatment reduced cold symptoms and inflammatory symptoms of sinusitis. Andrographis is used in traditional Ayurvedic and Chinese medicine for respiratory infections.

Andrographolide is the principal bioactive diterpene in Andrographis paniculata and the compound responsible for its anti-inflammatory and immune-modulatory effects studied in URTIs including sinusitis. Clinical trials of Kan Jang (standardized andrographolide preparation) showed reduced sinusitis symptoms in double-blind trials.

Bee propolis has the same evidence as propolis above—in vitro antibiofilm activity against chronic rhinosinusitis pathogens confirmed in a 2023 PMC study, traditional use for respiratory infections, and inclusion in combination sinusitis support products. Antimicrobial and anti-inflammatory mechanisms are established.

Boswellic acids from Boswellia serrata inhibit 5-LOX and NF-κB, reducing sinus mucosal inflammation. A 2023 case-control study (MDPI) evaluated an oral supplement containing Boswellia serrata plus bromelain for chronic sinusitis, finding improvements in nasal findings and inflammatory markers. Traditional use in Ayurvedic medicine for respiratory inflammation is established.

Boswellic acids are the active anti-inflammatory constituents of Boswellia serrata, directly responsible for 5-LOX inhibition and NF-κB suppression relevant to sinus mucosal inflammation. Clinical studies of Boswellia serrata extract (standardized to boswellic acids) include a 2023 case-control study for chronic sinusitis.

Bromelain, a proteolytic enzyme from pineapple stem, is approved by the German Commission E for treatment of sinus and nasal swelling. A 2013 pilot study (PubMed PMID 24273953) found good tolerability and symptom improvement in chronic rhinosinusitis. A 2006 German study in children with acute sinusitis also reported therapeutic benefit.

Intranasal capsaicin is a recognized treatment option for non-allergic rhinitis, with multiple clinical trials and a Cochrane review confirming efficacy. It desensitizes TRPV1 receptors in nasal mucosa, reducing congestion, nasal pain, headache, and sinus pressure. Evidence is for rhinitis/sinus symptoms rather than infectious sinusitis per se.

Capsicum (the plant genus providing capsaicin) has clinical evidence for intranasal use in rhinitis and sinus pressure relief. A randomized placebo-controlled trial of Capsicum annuum-based intranasal spray showed improvement in nasal symptom score, sinus pressure, and headache in rhinitis patients.

1,8-Cineole (eucalyptol) is the pharmacologically active compound in eucalyptus oil with the strongest clinical evidence for sinusitis: a placebo-controlled RCT (Kehrl et al., 2004) found 200 mg three times daily significantly improved rhinosinusitis symptom scores versus placebo after 7 days.

Multiple RCTs and a 2024 meta-analysis of 30 clinical trials (n=5,652) show Echinacea significantly reduces RTI occurrence (RR=0.68) and sinusitis complications (RR=0.44). A pediatric RCT found Echinacea reduced bacterial complications including sinusitis versus vitamin C control. Evidence for prevention is stronger than for acute treatment of established sinusitis.

Echinacea purpurea is the most studied species in RTI and sinusitis research. A pediatric RCT demonstrated it reduced viral RTIs leading to bacterial sinusitis complications compared to vitamin C control. The meta-analysis ERA-PRIMA (2024) specifically included E. purpurea preparations in trials documenting reduced sinusitis complications.

Eucalyptus oil (cineole/1,8-cineole) has clinical evidence for sinusitis: a randomized double-blind placebo-controlled trial of cineole capsules for acute non-purulent rhinosinusitis demonstrated significant improvement over placebo. Cineole is a mucolytic and anti-inflammatory agent approved in Germany for sinusitis.

Elderberry extract has demonstrated in vitro antimicrobial activity against Streptococcus pyogenes, Branhamella catarrhalis (key sinus pathogens), and influenza viruses—the main drivers of acute sinusitis. Traditional use of elderberry for cold-related sinus symptoms is well documented. No clinical trials have specifically enrolled sinusitis patients.

Garlic contains allicin with broad-spectrum antimicrobial properties. A 2021 SAGE-published study (Shahid et al., Nutrition and Food Sciences) demonstrated significant antibacterial and antibiofilm activity of garlic varieties against clinical sinusitis isolates. Traditional use spans Ayurveda and TCM for nasal congestion and respiratory infections.

Garlic bulb has the same antimicrobial and antibiofilm profile as garlic, with a 2021 published study showing activity against sinusitis bacterial isolates. Traditional use across cultures for sinus congestion is well-documented.

Gentian root is a component of Sinupret (BNO-101), a standardized herbal combination that has been evaluated in multiple RCTs for sinusitis. A systematic review identified 22 studies with Sinupret including 6 controlled trials; meta-analysis of 4 RCTs (~900 patients) showed Sinupret significantly superior to placebo as adjunct to antibiotics for acute sinusitis. Sinupret is approved for acute and chronic paranasal sinus inflammation in Germany.

Gentian root is a key ingredient in the clinically studied herbal formula Sinupret, used for over 80 years for sinusitis. A controlled study in 184 children given Sinupret plus saline rinse showed significantly improved nasal congestion, discharge, and postnasal drip compared to saline alone. A mouse model showed Sinupret reduced bacterial growth in bacterial sinusitis. Gentian's specific contribution within the multi-herb formula cannot be isolated.

Pelargonium sidoides EPs 7630 has clinical evidence and EMA-recognized status for sinusitis treatment. A Cochrane review noted possible efficacy for acute rhinosinusitis. A 2025 PMC review specifically examined immunomodulatory effects of P. sidoides for acute rhinosinusitis.

Green chiretta has been evaluated in clinical and review contexts for sinusitis, with a 2021 Life journal review finding it effective for acute respiratory tract infections including sinusitis. Its antiviral, antibacterial, and anti-inflammatory properties are pharmacologically relevant to sinus infection management.

Honey, particularly Manuka honey, has demonstrated antibiofilm activity against chronic rhinosinusitis pathogens in vitro superior to common antibiotics in some studies. A clinical trial (Di Stadio et al., Healthcare 2022) included honey in a nutraceutical protocol for upper RTI/sinusitis. Traditional use across cultures for respiratory infections is established.

Horseradish contains allyl isothiocyanate that stimulates nasal mucous membranes to thin and expel mucus. A published cohort study (Arzneimittelforschung) found herbal preparations containing horseradish and nasturtium recovered as quickly as antibiotic-treated patients in acute sinusitis. It has long been used in European folk medicine for sinus congestion.

Menthol (from peppermint and other Mentha species) activates TRPM8 cold receptors in nasal mucosa to create nasal patency sensation and is used in multiple OTC sinus relief products. Clinical evidence supports its subjective decongestant effect for sinus congestion symptoms.

NAC functions as a mucolytic agent in sinusitis by breaking disulfide bonds in mucopolysaccharide fibers, reducing mucus viscosity, and disrupting bacterial biofilms. A 2024 narrative review in Sage Journals identified NAC among supplements with 'growing positive evidence' for sinusitis. A clinical trial (NCT04123405) specifically investigated NAC for acute uncomplicated rhinosinusitis.

Nasturtium (Tropaeolum majus) herb contains isothiocyanates with documented antimicrobial properties relevant to sinus infections. It is a component of the clinically-studied German herbal preparation Angocin Anti-Infekt N, shown in a cohort study (Arzneimittelforschung) to be as effective as antibiotics in acute sinusitis.

Pelargonium sidoides (EPs 7630) has clinical evidence from a randomized double-blind placebo-controlled trial specifically for acute rhinosinusitis. A Cochrane systematic review (2008) found significant treatment effects in one sinusitis study (n=103 adults, RR=0.43 for complete resolution). It is an established phytopharmaceutical for URTIs in Germany.

Peppermint oil (menthol component) creates nasal patency sensation and has mild decongestant effects relevant to sinus congestion. NCCIH has published information on peppermint oil for respiratory uses. Multiple integrative medicine resources cite peppermint for opening nasal passages and relieving sinus pressure.

Clinical trials specifically in acute sinusitis show bromelain accelerates symptom resolution. Its antibacterial properties complement anti-inflammatory effects. A cohort study in 116 pediatric patients documented statistically faster recovery with bromelain monotherapy versus standard pharmaceutical treatment.

Bee propolis has documented antimicrobial and antibiofilm activity against bacteria isolated from patients with chronic rhinosinusitis. A 2023 in vitro study (PMC 10674846) showed NAC/propolis combinations effective against biofilms from chronic sinusitis pathogens. Traditional use across cultures for respiratory infections is established.

Quercetin inhibits mast cell degranulation and NF-κB signaling, reducing histamine release and pro-inflammatory cytokines relevant to sinusitis. A 2024 narrative review in SAGE Open Medicine identified quercetin among supplements with growing positive evidence for sinusitis. It is often combined with bromelain for sinus-related inflammation.

Serratiopeptidase has clinical evidence for reducing symptoms of sinusitis, a condition frequently involving infection-driven inflammation and mucus hypersecretion. The Mazzone et al. 1990 multicenter RCT in 193 ENT patients (including sinusitis) found significant symptom regression. SRP also exhibits anti-biofilm activity that may reduce bacterial persistence in sinus infections. Evidence quality is modest.

Vitamin C is consistently identified in sinusitis treatment reviews as an immune-boosting and antioxidant nutrient. A 2024 narrative review (SAGE Open Medicine) identified vitamin C among supplements with growing positive evidence for sinusitis. It is routinely recommended by naturopathic practitioners and immune-support guidelines for sinus infections.

Vitamin D deficiency is associated with increased susceptibility to respiratory infections including sinusitis. A 2024 SAGE Open Medicine narrative review specifically identified vitamin D among supplements with 'growing positive evidence' for sinusitis. Vitamin D supports antimicrobial peptide production in nasal and sinus mucosa.

Zinc lozenges and nasal gels have clinical evidence for shortening the duration of colds that precede sinusitis, and zinc supplementation may reduce the likelihood of sinusitis developing from viral URTIs. Multiple studies confirm zinc reduces cold symptom intensity and duration, and several authoritative sinusitis treatment resources include zinc as a supportive supplement.

Bayberry was traditionally used for sinusitis as a component of composition powder and as an astringent decongestant in herbal practice. Contemporary herbalists specifically cite sinusitis among bayberry's indications. The antimicrobial and astringent properties of bayberry constituents underpin this use.

Berberine, the principal alkaloid in goldenseal, barberry, and Oregon grape, has documented in vitro antimicrobial activity against common sinus pathogens. It is used in Traditional Chinese Medicine (Coptis chinensis) for respiratory infections. Specific clinical trials for sinusitis are absent; support is primarily traditional and mechanistic.

Cajuput oil is documented as a traditional remedy for sinusitis across Southeast Asian, Australian, and European practice, and is used in licensed OTC nasal inhalant products for sinus symptoms. Its 1,8-cineole content has been shown to reduce mucin secretion in sinus tissue ex vivo (PMC4514714) and oral 1,8-cineole has been tested in rhinosinusitis RCTs. Cajuput-specific clinical trials are absent.

Chymotrypsin has been used clinically for sinus infections based on its mucolytic and anti-infective properties, documented in authoritative source summaries. WebMD/Natural Medicines and RxList both list sinus infections among its historically recognized uses, though controlled human trial evidence specific to sinusitis is insufficient.

Curcumin, the primary bioactive in turmeric, has anti-inflammatory properties (NF-κB inhibition, cytokine suppression) directly relevant to sinus mucosal inflammation. Traditional Ayurvedic use for sinus conditions is established; clinical RCTs specific to sinusitis are lacking.

Elder (Sambucus nigra flowers and berries) has historically been used in European folk medicine for upper respiratory infections including sinusitis. Elderflower is included in the multi-ingredient product Sinupret studied for rhinosinusitis. Traditional and limited modern evidence supports its respiratory use.

Elderberry (Sambucus nigra) has been used in European and North American folk medicine for centuries for sinus infections and upper respiratory catarrh. Modern research focuses on influenza and URTI; a systematic review (PMC 2021) found it shortens cold/flu duration. Limited direct sinusitis-specific evidence exists.

Ginger has been used in Ayurvedic and Traditional Chinese Medicine for respiratory congestion and sinus infections. Its bioactive compounds (gingerols, shogaols) have anti-inflammatory and antimicrobial properties studied in vitro. Direct clinical trials for sinusitis are lacking; traditional and mechanistic support is established.

Goldenrod is traditionally used for sinusitis in European and North American herbal medicine, recognized explicitly in the Herbal Reality professional database. Its anticatarrhal, anti-inflammatory, and mild antimicrobial properties are the proposed mechanisms. No clinical trials have assessed goldenrod for sinusitis specifically.

Goldenseal has been used traditionally by Native Americans and herbalists for mucous membrane infections including sinusitis. Its active alkaloids (berberine, hydrastine, canadine) show antimicrobial and anti-inflammatory activity in laboratory studies. Clinical trials specifically for sinusitis are lacking; evidence is primarily traditional and in vitro.

Licorice root (Glycyrrhiza glabra) has been used in TCM and Ayurvedic medicine for respiratory infections and sinus conditions. Glycyrrhizin and glycyrrhetinic acid have anti-inflammatory, antiviral, and expectorant properties. Direct clinical trials for sinusitis are lacking; evidence is traditional and mechanistic.

Sambucus nigra (European elder, elderberry/elderflower) has traditional use for sinusitis in European folk medicine and is a component of Sinupret, a multi-herb product studied for rhinosinusitis. Modern research focuses on influenza/URTI rather than sinusitis specifically.

Turmeric's active compound curcumin inhibits NF-κB and pro-inflammatory cytokines relevant to sinus mucosal inflammation. It has been used in Ayurvedic medicine for respiratory and sinus conditions. Clinical studies in sinusitis specifically are limited; anti-inflammatory mechanisms provide biological plausibility.

Nasosinusitis is listed as a primary indication for Cang-Er-Zi (X. strumarium fruit) within the Chinese Pharmacopoeia and in numerous classical TCM monographs. X. strumarium is also documented in ethnomedicine across Bangladesh and India for infectious sinus complaints. Preclinical antimicrobial data support biological plausibility but human clinical evidence is absent.

Yellow Root is documented in traditional Appalachian and folk medicine as a remedy for sinus infections due to its antimicrobial and anti-inflammatory properties. It is noted in ethnobotanical sources alongside berberine-rich goldenseal, which shares this indication. No clinical trials on Yellow Root for sinusitis have been identified.